$INTC
Intel Corp Stock $intc

$intc Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000005086324000124 Filed on August 02, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$13.28B	$12.83B
YoY Change	2.59%	9.54%
Cost Of Revenue	$11.29B	$8.286B
YoY Change	35.81%	7.51%
Gross Profit	$1.997B	$4.547B
YoY Change	-56.94%	13.45%
Gross Profit Margin	15.03%	35.43%
Selling, General & Admin	$1.383B	$1.329B
YoY Change	0.66%	2.0%
% of Gross Profit	69.25%	29.23%
Research & Development	$4.049B	$4.239B
YoY Change	-0.76%	3.16%
% of Gross Profit	202.75%	93.23%
Depreciation & Amortization	$3.612B	$2.569B
YoY Change	58.7%	35.14%
% of Gross Profit	180.87%	56.5%
Operating Expenses	$11.05B	$6.511B
YoY Change	102.68%	18.9%
Operating Profit	-$9.057B	-$1.964B
YoY Change	1009.93%	33.79%
Interest Expense	-$29.00M	-$94.00M
YoY Change	-138.67%	-148.7%
% of Operating Profit
Other Income/Expense, Net	$130.0M	$80.00M
YoY Change	4.0%	-43.26%
Pretax Income	-$9.086B	-$2.004B
YoY Change	1013.48%	73.06%
Income Tax	$7.903B	-$350.0M
% Of Pretax Income
Net Earnings	-$16.64B	-$1.610B
YoY Change	-1223.5%	-41.62%
Net Earnings / Revenue	-125.26%	-12.55%
Basic Earnings Per Share	-$3.88	-$0.38
Diluted Earnings Per Share	-$3.88	-$0.38
COMMON SHARES
Basic Shares Outstanding	4.276B shares	4.257B shares
Diluted Shares Outstanding	4.292B shares	4.267B shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.09B	$29.27B
YoY Change	-0.7%	6.32%
Cash & Equivalents	$8.785B	$11.29B
Short-Term Investments	$15.30B	$17.99B
Other Short-Term Assets	$6.868B	$7.181B
YoY Change	66.74%	82.26%
Inventory	$12.06B	$11.24B
Prepaid Expenses
Receivables	$3.121B	$3.131B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$46.14B	$50.83B
YoY Change	6.41%	5.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$104.2B	$103.4B
YoY Change	14.63%	20.6%
Goodwill	$24.68B	$27.44B
YoY Change	-10.55%	-0.54%
Intangibles	$3.975B	$4.383B
YoY Change	-23.16%	-21.27%
Long-Term Investments	$3.000M	$4.000M
YoY Change	-99.95%	-60.0%
Other Assets	$9.006B	$14.33B
YoY Change	-28.92%	18.74%
Total Long-Term Assets	$147.4B	$155.4B
YoY Change	3.61%	13.42%
TOTAL ASSETS
Total Short-Term Assets	$46.14B	$50.83B
Total Long-Term Assets	$147.4B	$155.4B
Total Assets	$193.5B	$206.2B
YoY Change	4.26%	11.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.07B	$9.618B
YoY Change	26.46%	18.99%
Accrued Expenses	$17.88B	$15.86B
YoY Change	32.02%	14.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.765B	$4.695B
YoY Change	38.88%	226.72%
Total Short-Term Liabilities	$35.16B	$32.03B
YoY Change	29.36%	16.92%
LONG-TERM LIABILITIES
Long-Term Debt	$46.47B	$48.33B
YoY Change	0.29%	-1.03%
Other Long-Term Liabilities	$7.048B	$5.410B
YoY Change	-7.78%	11.78%
Total Long-Term Liabilities	$53.52B	$53.74B
YoY Change	-0.85%	0.13%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.16B	$32.03B
Total Long-Term Liabilities	$53.52B	$53.74B
Total Liabilities	$88.68B	$85.77B
YoY Change	4.81%	5.8%
SHAREHOLDERS EQUITY
Retained Earnings	$49.05B	$66.16B
YoY Change	-27.04%	0.78%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$99.53B	$115.2B
YoY Change
Total Liabilities & Shareholders Equity	$193.5B	$206.2B
YoY Change	4.26%	11.28%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$16.64B	-$1.610B
YoY Change	-1223.5%	-41.62%
Depreciation, Depletion And Amortization	$3.612B	$2.569B
YoY Change	58.7%	35.14%
Cash From Operating Activities	$4.054B	$2.292B
YoY Change	44.37%	-228.4%
INVESTING ACTIVITIES
Capital Expenditures	$6.458B	$5.682B
YoY Change	9.68%	-23.35%
Acquisitions
YoY Change
Other Investing Activities	$3.694B	-$3.483B
YoY Change	19.94%	373.88%
Cash From Investing Activities	-$2.764B	-$9.165B
YoY Change	-1.57%	7.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.792B	11.24B
YoY Change	-3341.03%	51.97%
NET CHANGE
Cash From Operating Activities	4.054B	2.292B
Cash From Investing Activities	-2.764B	-9.165B
Cash From Financing Activities	-3.792B	11.24B
Net Change In Cash	-2.502B	4.364B
YoY Change	-2238.46%	-249.86%
FREE CASH FLOW
Cash From Operating Activities	$4.054B	$2.292B
Capital Expenditures	$6.458B	$5.682B
Free Cash Flow	-$2.404B	-$3.390B
YoY Change	-21.95%	-63.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7511000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4208000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2795000000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11287000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11144000000	usd
	us-gaap	Profit Loss ProfitLoss	-1295000000	usd
	us-gaap	Depreciation Depreciation	3733000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1661000000	usd
	us-gaap	Restructuring Charges RestructuringCharges	255000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	909000000	usd
	intc	Non Cash Gains Losses On Equity Investments Net NonCashGainsLossesOnEquityInvestmentsNet	146000000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	17634000000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	25696000000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	17214000000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	26957000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1063000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2036000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-444000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-453000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8349000000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5544000000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5113000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	104471000000	usd
CY2024Q2	us-gaap	Debt Current DebtCurrent	4695000000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	2288000000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	9618000000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8578000000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2651000000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3655000000	usd
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4276000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4228000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4228000000	shares
CY2023Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	36649000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-215000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	69156000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	105590000000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	4375000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	109965000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	191572000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-272000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1137000000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	116000000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1240000000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	184000000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1102000000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1309000000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1340000000	usd
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-2174000000	usd
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-2186000000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1983000000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1843000000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	3160000000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	2318000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1069000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1023000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11652000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13301000000	usd
	intc	Proceeds From Capital Grants ProceedsFromCapitalGrants	699000000	usd
	intc	Proceeds From Capital Grants ProceedsFromCapitalGrants	49000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	355000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-662000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11728000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11329000000	usd
	us-gaap	Proceeds From Issuance Of Commercial Paper ProceedsFromIssuanceOfCommercialPaper	5804000000	usd
	us-gaap	Proceeds From Issuance Of Commercial Paper ProceedsFromIssuanceOfCommercialPaper	0	usd
	us-gaap	Repayments Of Commercial Paper RepaymentsOfCommercialPaper	2609000000	usd
	us-gaap	Repayments Of Commercial Paper RepaymentsOfCommercialPaper	3944000000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	96000000	usd
	intc	Proceeds From Partner Contributions ProceedsFromPartnerContributions	11861000000	usd
	intc	Proceeds From Partner Contributions ProceedsFromPartnerContributions	834000000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1573000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2975000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	10968000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2288000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	631000000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	665000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14867000000	usd
	intc	Noncash Capital Related Government Assistance NoncashCapitalRelatedGovernmentAssistance	1281000000	usd
	intc	Noncash Capital Related Government Assistance NoncashCapitalRelatedGovernmentAssistance	46000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	488000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	161000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1555000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1520000000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	110756000000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1654000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-154000000	usd
CY2024Q2	intc	Noncontrolling Interest Increase From Sale Of Parent Equity Interest And Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSaleOfParentEquityInterestAndSubsidiaryEquityIssuance	11438000000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	5000000	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	780000000	usd
CY2024Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	203000000	usd
CY2024Q2	us-gaap	Dividends Common Stock DividendsCommonStock	534000000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	120434000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	100403000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	1473000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-125000000	usd
CY2023Q3	intc	Noncontrolling Interest Increase From Sale Of Parent Equity Interest And Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSaleOfParentEquityInterestAndSubsidiaryEquityIssuance	1958000000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	6000000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	922000000	usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	166000000	usd
	us-gaap	Profit Loss ProfitLoss	-2091000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-481000000	usd
	intc	Noncontrolling Interest Increase From Sale Of Parent Equity Interest And Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSaleOfParentEquityInterestAndSubsidiaryEquityIssuance	11861000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	631000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1959000000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	347000000	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	1063000000	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4276000000	shares
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	120434000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	103286000000	usd
	us-gaap	Profit Loss ProfitLoss	-1295000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	18000000	usd
	intc	Noncontrolling Interest Increase From Sale Of Parent Equity Interest And Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSaleOfParentEquityInterestAndSubsidiaryEquityIssuance	2407000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	665000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1661000000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	235000000	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	2036000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	104471000000	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	222000000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12833000000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12949000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25557000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24664000000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1964000000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1016000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3033000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2484000000	usd
CY2024Q2	us-gaap	Minority Interest MinorityInterest	5205000000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	4375000000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1654000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	1473000000	usd
	us-gaap	Profit Loss ProfitLoss	-2091000000	usd
	us-gaap	Profit Loss ProfitLoss	-1295000000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-44000000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-18000000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1610000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1481000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1991000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1277000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4267000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4182000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4254000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4168000000	shares
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	14000000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4267000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4196000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4254000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4168000000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
	us-gaap	Accounts Receivable Sale AccountsReceivableSale	1000000000.0	usd
	us-gaap	Accounts Receivable Sale AccountsReceivableSale	1000000000.0	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1284000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1166000000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6294000000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6203000000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3666000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3758000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	11244000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	11127000000	usd
CY2024Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	3000000000.0	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	2900000000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	320000000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	313000000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	643000000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	647000000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	294000000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	214000000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	552000000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	407000000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	54000000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	125000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	134000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	125000000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	80000000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	224000000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	225000000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	365000000	usd
CY2024Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	374000000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	737000000	usd
CY2023Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	381000000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	744000000	usd
CY2024Q2	us-gaap	Severance Costs1 SeveranceCosts1	165000000	usd
CY2023Q3	us-gaap	Severance Costs1 SeveranceCosts1	171000000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	294000000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	132000000	usd
CY2024Q2	intc	Litigation Charges And Other LitigationChargesAndOther	778000000	usd
CY2023Q3	intc	Litigation Charges And Other LitigationChargesAndOther	20000000	usd
	intc	Litigation Charges And Other LitigationChargesAndOther	778000000	usd
	intc	Litigation Charges And Other LitigationChargesAndOther	97000000	usd
	intc	Litigation Charges And Other LitigationChargesAndOther	97000000	usd
CY2024Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	9000000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	219000000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	35000000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	35000000	usd
CY2024Q2	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	943000000	usd
CY2023Q3	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	200000000	usd
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	1291000000	usd
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	264000000	usd
CY2024Q2	us-gaap	Severance Costs1 SeveranceCosts1	165000000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	294000000	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	222000000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2004000000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-816000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2723000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1974000000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-350000000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2289000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-632000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-679000000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.175
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	2.805
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.232
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.344
CY2024Q2	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-139000000	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-366000000	usd
CY2023Q3	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-183000000	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-91000000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	7700000000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4700000000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	11498000000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1987000000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	6141000000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	241000000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	5396000000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	25263000000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	1246000000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	1194000000	usd
CY2024Q2	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	4574000000	usd
CY2023Q4	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	4630000000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	4000000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5000000	usd
CY2024Q2	intc	Equity Investments EquityInvestments	5824000000	usd
CY2023Q4	intc	Equity Investments EquityInvestments	5829000000	usd
	intc	Marketable Securities Trading Volume Restrictions Shares Owned Threshold Percentage MarketableSecuritiesTradingVolumeRestrictionsSharesOwnedThresholdPercentage	0.01
CY2024Q2	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-43000000	usd
CY2023Q3	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-85000000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-134000000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	103000000	usd
CY2024Q2	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	25000000	usd
CY2023Q3	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	0	usd
	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	49000000	usd
	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	10000000	usd
CY2024Q2	us-gaap	Impairment Of Investments ImpairmentOfInvestments	91000000	usd
CY2023Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	38000000	usd
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	159000000	usd
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	74000000	usd
CY2024Q2	intc	Other Net Equity Investments OtherNetEquityInvestments	-11000000	usd
CY2023Q3	intc	Other Net Equity Investments OtherNetEquityInvestments	99000000	usd
	intc	Other Net Equity Investments OtherNetEquityInvestments	329000000	usd
	intc	Other Net Equity Investments OtherNetEquityInvestments	106000000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-120000000	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-24000000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	85000000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	145000000	usd
CY2024Q2	us-gaap	Repayments Of Commercial Paper RepaymentsOfCommercialPaper	2600000000	usd
CY2024Q2	us-gaap	Commercial Paper CommercialPaper	3200000000	usd
CY2023Q4	us-gaap	Commercial Paper CommercialPaper	0	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	1246000000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	1194000000	usd
CY2024Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	52724000000	usd
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	50530000000	usd
CY2024Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	706000000	usd
CY2024Q2	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2024Q2	us-gaap	Derivative Assets DerivativeAssets	706000000	usd
CY2024Q2	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	331000000	usd
CY2024Q2	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	375000000	usd
CY2024Q2	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2024Q2	us-gaap	Securities Purchased Under Agreements To Resell Gross SecuritiesPurchasedUnderAgreementsToResellGross	2915000000	usd
CY2024Q2	us-gaap	Securities Purchased Under Agreements To Resell Liability SecuritiesPurchasedUnderAgreementsToResellLiability	0	usd
CY2024Q2	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	2915000000	usd
CY2024Q2	us-gaap	Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2024Q2	us-gaap	Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities	2915000000	usd
CY2024Q2	us-gaap	Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2024Q2	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross	3621000000	usd
CY2024Q2	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0	usd
CY2024Q2	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed	3621000000	usd
CY2024Q2	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction	331000000	usd
CY2024Q2	intc	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash	3290000000	usd
CY2024Q2	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2024Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1178000000	usd
CY2024Q2	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2024Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1178000000	usd
CY2024Q2	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	331000000	usd
CY2024Q2	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	742000000	usd
CY2024Q2	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	105000000	usd
CY2024Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1178000000	usd
CY2024Q2	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2024Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	1178000000	usd
CY2024Q2	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	331000000	usd
CY2024Q2	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	742000000	usd
CY2024Q2	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	105000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1047000000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	1047000000	usd
CY2023Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	617000000	usd
CY2023Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	430000000	usd
CY2023Q4	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2023Q4	us-gaap	Securities Purchased Under Agreements To Resell Gross SecuritiesPurchasedUnderAgreementsToResellGross	2554000000	usd
CY2023Q4	us-gaap	Securities Purchased Under Agreements To Resell Liability SecuritiesPurchasedUnderAgreementsToResellLiability	0	usd
CY2023Q4	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	2554000000	usd
CY2023Q4	us-gaap	Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2023Q4	us-gaap	Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities	2554000000	usd
CY2023Q4	us-gaap	Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2023Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross	3601000000	usd
CY2023Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0	usd
CY2023Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed	3601000000	usd
CY2023Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction	617000000	usd
CY2023Q4	intc	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash	2984000000	usd
CY2023Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1111000000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1111000000	usd
CY2023Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	617000000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	399000000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	95000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1111000000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1111000000	usd
CY2023Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	617000000	usd
CY2023Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	399000000	usd
CY2023Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	95000000	usd
CY2024Q2	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	-24000000	usd
CY2023Q3	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	213000000	usd
	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	120000000	usd
	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	21000000	usd
CY2024Q2	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	usd
CY2023Q3	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	usd
	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	usd
	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="margin-bottom:9pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#0068b5;border-bottom:1pt solid #0068b5;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Note 13 : </span></td><td colspan="3" style="border-bottom:1pt solid #0068b5;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are regularly party to various ongoing claims, litigation, and other proceedings, including those noted in this section. We have accrued a charge of $1.0 billion related to litigation involving VLSI (see VLSI Technology LLC v. Intel below), a charge of $780 million related to three separate confidential agreements with R2, Third Point, and TRGP we anticipate entering into (see R2 Semiconductor Patent Litigation below), and a charge of $401 million related to an EC-imposed fine (see European Commission Competition Matter below). Excluding the VLSI claims and the R2 matter, management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends; however, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings, excessive verdicts, or other events could occur. Unfavorable resolutions could include substantial monetary damages, fines, or penalties. Certain of these outstanding matters include speculative, substantial, or indeterminate monetary awards. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Unless specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">European Commission Competition Matter </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2009, the EC found that we had used unfair business practices to persuade customers to buy microprocessors in violation of Article 82 of the EC Treaty (later renumbered Article 102) and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 by offering alleged “conditional rebates and payments” that required customers to purchase all or most of their x86 microprocessors from us and by making alleged “payments to prevent sales of specific rival products.” The EC ordered us to end the alleged infringement referred to in its decision and imposed a €1.1 billion fine, which we paid in the third quarter of 2009.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We appealed the EC decision to the European Court of Justice in 2014, after the General Court (then called the Court of First Instance) rejected our appeal of the EC decision in its entirety. In September 2017, the Court of Justice sent the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. In January 2022, the General Court annulled the EC’s 2009 findings against us regarding rebates, as well as the €1.1 billion fine imposed on Intel, which was returned to us in February 2022. The General Court’s January 2022 decision did not annul the EC’s 2009 finding that we made payments to prevent sales of specific rival products.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In April 2022 the EC appealed the General Court’s decision to the Court of Justice, which has indicated it will deliver its judgment in October 2024. In addition, in September 2023 the EC imposed a €376 million ($401 million) fine against us based on its finding that we made payments to prevent sales of specific rival products. We have appealed the EC’s decision. We have accrued a charge for the fine and are unable to make a reasonable estimate of the potential loss or range of losses in excess of this amount given the procedural posture and the nature of these proceedings.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In a related matter, in April 2022 we filed applications with the General Court seeking an order requiring the EC to pay us approximately €593 million in default interest on the original €1.1 billion fine that was held by the EC for 12 years, which applications have been stayed pending the EC’s appeal of the General Court’s January 2022 decision.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation Related to Security Vulnerabilities </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2017, a Google research team notified Intel and other companies that it had identified security vulnerabilities, the first variants of which are now commonly referred to as “Spectre” and “Meltdown,” that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. In January 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of July 31, 2024, consumer class action lawsuits against us were pending in the US and Canada. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by our actions and/or omissions in connection with Spectre, Meltdown, and other variants of this class of security vulnerabilities that have been identified since 2018, and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the US, class action suits filed in various jurisdictions between 2018 and 2021 were consolidated for all pretrial proceedings in the US District Court for the District of Oregon, which entered final judgment in favor of Intel in July 2022 based on plaintiffs’ failure to plead a viable claim. The Ninth Circuit Court of Appeals affirmed the district court’s judgment in November 2023, ending the litigation. In November 2023, new plaintiffs filed a consumer class action complaint in the US District Court for the Northern District of California with respect to a further vulnerability variant disclosed in August 2023 and commonly referred to as “Downfall.” We moved to dismiss that complaint in January 2024. In Canada, an initial status conference has not yet been scheduled in one case relating to Spectre and Meltdown pending in the Superior Court of Justice of Ontario, and a stay of a second case pending in the Superior Court of Justice of Quebec is in effect.</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. Given the procedural posture and the nature of these cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from these matters.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation Related to 7nm Product Delay Announcement </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Multiple securities class action lawsuits were filed in the US District Court for the Northern District of California against us and certain officers following our July 2020 announcement of 7nm product delays. The court consolidated the lawsuits and appointed lead plaintiffs in October 2020, and in January 2021 plaintiffs filed a consolidated complaint. Plaintiffs purported to represent all persons who purchased or otherwise acquired our common stock from October 25, 2019 through October 23, 2020, and they generally alleged that defendants violated the federal securities laws by making false or misleading statements about the timeline for 7nm products. The district court granted the defendants’ motion to dismiss the consolidated complaint and entered judgment in April 2023. The Ninth Circuit affirmed the district court’s judgment in April 2024, and plaintiffs did not appeal the Ninth Circuit’s ruling. </span></div><div style="margin-bottom:9pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Litigation Related to Patent and IP Claims</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have had IP infringement lawsuits filed against us, including but not limited to those discussed below. Most involve claims that certain of our products, services, and technologies infringe others' IP rights. Adverse results in these lawsuits may include awards of substantial fines and penalties, costly royalty or licensing agreements, or orders preventing us from offering certain features, functionalities, products, or services. As a result, we may have to change our business practices, and develop non-infringing products or technologies, which could result in a loss of revenue for us and otherwise harm our business. In addition, certain agreements with our customers require us to indemnify them against certain IP infringement claims, which can increase our costs as a result of defending such claims, and may require that we pay significant damages, accept product returns, or supply our customers with non-infringing products if there were an adverse ruling in any such claims. In addition, our customers and partners may discontinue the use of our products, services, and technologies, as a result of injunctions or otherwise, which could result in loss of revenue and adversely affect our business.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VLSI Technology LLC v. Intel </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2017, VLSI Technology LLC (VLSI) filed a complaint against us in the US District Court for the Northern District of California alleging that various Intel FPGA and processor products infringe eight patents VLSI acquired from NXP Semiconductors, N.V. (NXP). VLSI sought damages, attorneys’ fees, costs and interest. Intel prevailed on all eight patents and the court entered final judgment in April 2024. In April 2019, VLSI filed three infringement suits against us in the US District Court for the Western District of Texas accusing various of our processors of infringement of eight additional patents it had acquired from NXP:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">▪</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.46pt">The first Texas case went to trial in February 2021, and the jury awarded VLSI $1.5 billion for literal infringement of one patent and $675 million for infringement of another patent under the doctrine of equivalents. In April 2022, the court entered final judgment, awarding VLSI $2.2 billion in damages and approximately $162 million in pre-judgment and post-judgment interest. We appealed the judgment to the Federal Circuit Court of Appeals, including the court’s rejection of Intel’s claim to have a license from Fortress Investment Group’s acquisition of Finjan. The Federal Circuit Court heard oral argument in October 2023. In December 2023, the Federal Circuit reversed the finding of infringement as to the patent for which VLSI was awarded $675 million. The Federal Circuit affirmed the finding of infringement as to the patent for which VLSI had been awarded $1.5 billion, but vacated the damages award and sent the case back to the trial court for further damages proceedings on that patent. The Federal Circuit also ruled that Intel can advance the defense that it is licensed to VLSI’s patents. In December 2021 and January 2022 the Patent Trial and Appeal Board (PTAB) instituted Inter Partes Reviews (IPR) on the claims found to have been infringed in the first Texas case, and in May and June 2023 found all of those claims unpatentable; VLSI has appealed the PTAB’s decision. In March 2024, Intel filed a motion to stay the case pending appeals of the IPRs. In April 2024, Intel moved to add the defense that it is licensed to VLSI’s patents.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">▪</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.46pt">The second Texas case went to trial in April 2021, and the jury found that we do not infringe the asserted patents. VLSI had sought approximately $3.0 billion for alleged infringement, plus enhanced damages for willful infringement. The court has not yet entered final judgment.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">▪</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.46pt">The third Texas case went to trial in November 2022, with VLSI asserting one remaining patent. The jury found the patent valid and infringed, and awarded VLSI approximately $949 million in damages, plus interest and a running royalty. The court has not yet entered final judgment. In February 2023, we filed motions for a new trial and for judgment as a matter of law notwithstanding the verdict on various grounds. Further appeals are possible. In April 2024, Intel moved to add the defense that it is licensed to VLSI’s patents, and the court granted Intel’s motion that same month.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2019, VLSI filed a case in Shenzhen Intermediate People’s Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserted one patent against certain Intel Core processors. Defendants filed an invalidation petition in October 2019 with the China National Intellectual Property Administration (CNIPA) which held a hearing in September 2021. The Shenzhen court held trial proceedings in July 2021, and September 2023. VLSI sought an injunction as well as RMB 1.3 million in costs and expenses, but no damages. In September 2023, the CNIPA invalidated every claim of the asserted patent. In November 2023, the trial court dismissed VLSI’s case.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2019, VLSI filed a case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. asserting one patent against certain Intel core processors. The court held a trial hearing in December 2020, where VLSI requested expenses (RMB 300 thousand) and an injunction. In December 2022, we filed a petition to invalidate the patent at issue. The court held a second trial hearing in May 2022, and in October 2023, issued a decision finding no infringement and dismissing all claims. In November 2023, VLSI appealed the finding of non-infringement.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In July 2024, Intel filed suit against VLSI in U.S. District Court for the District of Delaware requesting the court find Intel is licensed to VLSI’s patents.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June 29, 2024, we have accrued a charge of approximately $1.0 billion related to the VLSI litigation. While we dispute VLSI’s claims and intend to vigorously defend against them, we are unable to make a reasonable estimate of losses in excess of recorded amounts given recent developments and future proceedings.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R2 Semiconductor Patent Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2022, R2 Semiconductor, Inc. (R2) filed a lawsuit in the High Court of Justice in the UK against Intel Corporation (UK) Limited and Intel Corporation, and a lawsuit in the Dusseldorf Regional Court in Germany against Intel Deutschland GmbH and certain Intel customers. R2 asserts one European patent is infringed by Intel’s Ice Lake, Tiger Lake, Alder Lake and Ice Lake Server (Xeon) processors (the accused products), and customer servers and laptops that contain those processors. R2 seeks an injunction in both actions prohibiting the sale and requiring the recall of the alleged infringing products. Intel is indemnifying its customers in the German lawsuit.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intel disputes R2’s claims and intends to defend the lawsuits vigorously. In December 2022, Intel responded in the UK action that the asserted patent is not infringed and that the patent is invalid. Trial in the UK matter took place in April 2024. In July 2024, the UK High Court of Justice found the UK part of R2’s European patent invalid.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In April 2023, defendants filed statements of defense in the German action that the asserted patent is not infringed and that an injunction would be a disproportionate remedy. In May 2023, defendants also filed a nullity action in the German Federal Patent Court on the ground that the asserted patent is invalid.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2023, the German Federal Patent Court issued a preliminary opinion finding R2’s patent valid. A trial in the German Federal Patent Court, followed by a decision on validity is expected in October 2024. In December 2023, the court in Dusseldorf held a trial on the issue of infringement. In February 2024, the court found Intel’s processors infringe and issued an injunction and recall order against Intel and its customers. R2 has not yet sought to enforce the order. Intel has appealed the decision. In April 2024, Intel also filed a complaint with the Constitutional Court seeking a stay and a reversal of the finding of infringement and filed additional evidence with the appeals court to demonstrate that it does not infringe R2’s patent. In May 2024, the Constitutional Court declined to consider Intel’s complaint.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2024, R2 asserted the same patent against Fujitsu and Amazon Web Services in Dusseldorf Regional Court, accusing Ice Lake and Sapphire Rapids in the AWS suit; and Tiger Lake, Ice Lake, Alder Lake, Raptor Lake, and Sapphire Rapids in the Fujitsu suit. R2 seeks an injunction, recall and damages. Intel is indemnifying and defending its customers. In June 2024, defendants filed a writ setting out their defenses.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2024, Intel Corporation Italia S.P.A. filed an action in the Tribunale di Milano seeking an order that Intel processors do not infringe R2’s patent. In May 2024, R2 filed suit in Milan against Intel Corporation Italia S.P.A. and Italian affiliates of customers Dell, HP, and HPE, accusing Intel’s Ice Lake (server and client), Tiger Lake, Alder Lake, and Raptor Lake processors of infringing its patent, and requesting that its suit be consolidated with Intel Corporation Italia S.P.A.’s suit. R2 is requesting an injunction and damages. In June 2024, R2 responded to the suit filed by Intel Corporation Italia S.P.A. and asserted counterclaims of infringement against the same processors R2 accused in its suit.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In April 2024, R2 filed an action against Intel and its customers Dell, HP, and HPE for patent infringement in before the Tribunal Judiciaire of Paris. Intel and its customers have filed a nullity action against the patent in France.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In light of the potential disruption to Intel’s and its customers’ businesses in Europe were the Dusseldorf Regional Court’s injunction and recall order enforced before a decision by the appeals court is expected, the significant delay expected before a decision by the appeals court, and the additional ongoing and potential litigation across other jurisdictions and with respect to other Intel processors and customers, we are in negotiations to enter into three separate confidential agreements with R2, Third Point (the controlling shareholder) and TRGP Capital (a third-party organization funding the lawsuits) to resolve the injunction enforcement risk and related pending litigation, and provide for broad-based litigation peace with these entities, which may include rights to other technology and services to Intel. Based on the anticipated agreements, we recorded a current period charge of $780 million, substantially all of which is attributable to the proposed broad-based litigation peace.</span></div>
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
intc-20240629_cal.xml	Edgar Link	unprocessable
0000050863-24-000124-index-headers.html	Edgar Link	pending
0000050863-24-000124-index.html	Edgar Link	pending
0000050863-24-000124.txt	Edgar Link	pending
0000050863-24-000124-xbrl.zip	Edgar Link	pending
a06292024ex103.htm	Edgar Link	pending
a06292024ex311.htm	Edgar Link	pending
a06292024ex312.htm	Edgar Link	pending
a06292024ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
intc-20240629.htm	Edgar Link	pending
intc-20240629.xsd	Edgar Link	pending
intc-20240629_g1.jpg	Edgar Link	pending
intc-20240629_g10.jpg	Edgar Link	pending
intc-20240629_g11.jpg	Edgar Link	pending
intc-20240629_g12.jpg	Edgar Link	pending
intc-20240629_g13.jpg	Edgar Link	pending
intc-20240629_g14.jpg	Edgar Link	pending
intc-20240629_g15.jpg	Edgar Link	pending
intc-20240629_g16.jpg	Edgar Link	pending
intc-20240629_g17.jpg	Edgar Link	pending
intc-20240629_g18.jpg	Edgar Link	pending
intc-20240629_g19.jpg	Edgar Link	pending
intc-20240629_g2.jpg	Edgar Link	pending
intc-20240629_g20.jpg	Edgar Link	pending
intc-20240629_g21.jpg	Edgar Link	pending
intc-20240629_g22.jpg	Edgar Link	pending
intc-20240629_g23.jpg	Edgar Link	pending
intc-20240629_g24.jpg	Edgar Link	pending
intc-20240629_g25.jpg	Edgar Link	pending
intc-20240629_g26.jpg	Edgar Link	pending
intc-20240629_g27.jpg	Edgar Link	pending
intc-20240629_g3.jpg	Edgar Link	pending
intc-20240629_g4.jpg	Edgar Link	pending
intc-20240629_g5.jpg	Edgar Link	pending
intc-20240629_g6.jpg	Edgar Link	pending
intc-20240629_g7.jpg	Edgar Link	pending
intc-20240629_g8.jpg	Edgar Link	pending
intc-20240629_g9.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
intc-20240629_def.xml	Edgar Link	unprocessable
intc-20240629_lab.xml	Edgar Link	unprocessable
intc-20240629_pre.xml	Edgar Link	unprocessable
intc-20240629_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INTC
Intel Corp Stock $intc

2024 Q3 Form 10-Q Financial Statement

#000005086324000124 Filed on August 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTC Intel Corp Stock $intc

2024 Q3 Form 10-Q Financial Statement

#000005086324000124 Filed on August 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTC
Intel Corp Stock $intc